Immuneel
Immuneel Therapeutics Private Limited
Bangalore, India · $49.9M raised
- Headquarters
- Bangalore
- Employees
- 11–50
- Business Model
- B2C
- Website
- immuneel.com
- Total Funding
- $49.9M
- Last Round
- $12.0M Series BJun 2026
- Rounds
- 5
About
Clinical-stage Indian biotech pioneering CAR-T cell and gene therapies to make cancer treatments affordable in India.
Summary
Immuneel is a Biotech company based in Bangalore, India. It has raised $49.9M in total across 5 rounds, most recently a $12.0M Series B round in Jun 2026. Investors include Singularity AMC, Rainmatter and Eight Roads Ventures.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jun 2026
Sign up to see all 5 rounds
Seed through Series B — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immuneel"><img src="https://indexed.vc/api/badge/company/immuneel" alt="Immuneel on Indexed.vc" width="260" height="76" /></a>